36110-12-0Relevant articles and documents
3-Alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel openers: Effect of 6,7-disubstitution on potency and tissue selectivity
De Tullio, Pascal,Boverie, Stéphane,Becker, Bénédicte,Antoine, Marie-Hélène,Nguyen, Quynh-Anh,Francotte, Pierre,Counerotte, Stéphane,Sebille, Sophie,Pirotte, Bernard,Lebrun, Philippe
, p. 4990 - 5000 (2005)
A series of 6,7-disubstituted 4H-1,2,4-benzothiadiazine 1,1-dioxides bearing a short alkylamino side chain in the 3-position were synthesized. These compounds were tested on rat pancreatic islets and on rat aorta rings. In vitro data indicated that in mos
1,2,4-Benzothiadiazine-1,1-dioxide derivatives as Ionotropic glutamate receptor ligands: Synthesis and structure-activity relationships
Varano, Flavia,Catarzi, Daniela,Colotta, Vittoria,Squarcialupi, Lucia,Matucci, Rosanna
, p. 777 - 785 (2015/04/22)
Ionotropic glutamate receptor (iGluR) modulators, specially AMPA receptor antagonists, are potential tools for numerous therapeutic applications in neurological disorders, including Alzheimer's and Parkinson's diseases, amyotrophic lateral sclerosis, epil